VCYT price target
Veracyte, Inc. · end-of-day data as of Nov 13, 2026
Veracyte
$24.33-1.2%
PT $54.14 +122.5%▲ 7
- PT$54.14 +122.5%
- ConsensusBuy · 14
- P/E vs own-58.8%
- P/E vs sector-51.0%
- FCF yield+8.2%
- RSI28
- Sector▲ +15.9%
Neutral
- Earnings in103d
- P/E15.8x
- Support-4.4%
- Resistance+8.5%
- Off 52w high-60.1%
- Volume0.8x
- Bollingerlower half
- News0.00
- Trendsideways
- 52w range$22–$61
- ATR+14.5%
- Off ATH-71.7%
▼ 4
- Insiders-$2.86M
- MAs0 of 4
- MA20×50Death 3d ago
- MACD-2.50
Updates with the 15-min delayed price. Not a forecast or investment advice.
![]()
Summary
- Price target at+122.5%
- ConsensusBuy
Analyst price targets
7 firms with a target in the last 12 months · last close $24.33 · as of Nov 13, 2026
— actual price● bullish target● bearish target┄ last close, high, average and low targethover a dot to see the analysts behind it ·wheel or drag to move through time · drag the price axis on the right to stretch it · double-click resets
Guggenheim$502026-01-05
Morgan Stanley$482025-12-01
Morgan Stanley$372026-03-05
Canaccord Genuity$422026-05-06
Piper Sandler$542026-08-04
Stephens$552026-08-04
Canaccord Genuity$502026-08-03
Needham$692026-07-31
Piper Sandler$662026-07-15
Canaccord Genuity$602026-07-14
+4 more
Morgan Stanley$442026-08-04
UBS$652026-09-09
Needham$462026-11-05
Strong buy 2Buy 9Hold 3Sell 0Strong sell 0
14 analysts in November 2026: 11 rate it a buy or strong buy (79%) and 3 a hold. A year earlier, 75% rated it a buy or strong buy.